Final Assessment – Women’s Health Masterclass Webinar

Quiz Summary

0 of 5 Questions completed

Questions:

You have already completed the quiz before. Hence you can not start it again.

Quiz is loading…

You must sign in or sign up to start the quiz.

You must first complete the following:

Results

Quiz complete. Results are being recorded.

Results

0 of 5 Questions answered correctly

Your time:

You have reached 0 of 0 point(s), (0)

Current
Review
Answered
Correct
Incorrect

Question 1 of 5

1. Question
A 28 year old female comes to see you to discuss a 1 week history of vaginal itchiness and a white creamy discharge. The discharge is not offensive smelling. Just over 4 weeks ago she was given antibiotics for a sore throat. She is well and afebrile.

Q19. What is the single most appropriate management options?:
- A. Advise a likely STI and to the local GUM clinic for a full STI screen
- B. Offer metronidazole 400mg bd for 7 days
- C. Offer fluconazole 150mg as a single dose
- D. High vaginal swab before deciding on any treatment
- E. Hydrocortisone cream prn for vaginal itchiness
Correct

Incorrect
Question 2 of 5

2. Question
An 18 year old female comes to see you as she has a 4 day history of diarrhoea and vomiting which she says her partner had the week before.

Q20. Whilst assessing her likely viral induced gastroenteritis, what should you advise with regard to contraception (she is on microgynon) (COCP))? What is the most appropriate management option?:
- A. Double her microgynon dose until the diarrhoea and vomiting settles
- B. Use additional barrier contraception (eg condoms) until at least 7 days after the diarrhoea and vomiting settles
- C. Don’t advise anything and assume she will not have intercourse whilst she has diarrhoea and vomiting
- D. Advise that the microgynon will still be absorbed normally as long as she does not vomit within 2 hours of taking a tablet
- E. Persistent diarrhoea without vomiting does not affect efficacy of the COCP
Correct

Incorrect
Question 3 of 5

3. Question
Which one of the following is not a guiding principle of HRT?
- A. Continuous oestrogen and progestogen therapy (either in a single formulation or separate) is safest for women with a uterus
- B. Perimenopausal women who are still having regular/irregular periods (ie unstable endometrium) should be offered a sequential formula of HRT and not continuous
- C. For menopausal women who have stopped having periods continuous oestrogen and progestogen should be given as less likely to cause troublesome irregular bleeding
- D. If a Mirena IUS in situ oestrogen-only HRT can be given
- E. A Mirena IUS gives endometrial protection for 7 years
Correct

Incorrect
Question 4 of 5

4. Question
Which one of the following is not a feature of PCOS?
- A. Hirsutism
- B. Acne
- C. Oligomenorrhoea
- D. FSH:LH > 3:1
- E. Increased CV risk
Correct

Incorrect
Question 5 of 5

5. Question
Which one of the following statements about screening for cancer in women is correct?
- A. 60% of cervical cancers are caused by HPV infection
- B. In England, cervical screening is offered to women and people with a cervix who are aged 25–64 years
- C. Abdominal pain is the most common presentation of endometrial cancer
- D. COCP, breastfeeding and pregnancy increase the risk of ovarian cancer
- E. The HPV vaccine is more effective after an initial infection of HPV
Correct

Incorrect

Final Assessment – Women’s Health Masterclass Webinar

Quiz Summary

Information

Results

Results

Categories

1. Question

2. Question

3. Question

4. Question

5. Question